Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2001-11-15
pubmed:abstractText
Minichromosome maintenance protein 2 (MCM2) is a component of the prereplicative complex. It is essential for eukaryotic DNA replication and is only expressed in proliferating cells. The prognostic utility of MCM2 compared with Ki-67, another marker of proliferating cells, on survival of patients with non-small-cell lung cancer (NSCLC) was studied.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4259-66
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11709570-Adenocarcinoma, pubmed-meshheading:11709570-Adult, pubmed-meshheading:11709570-Aged, pubmed-meshheading:11709570-Aged, 80 and over, pubmed-meshheading:11709570-Carcinoma, Adenosquamous, pubmed-meshheading:11709570-Carcinoma, Large Cell, pubmed-meshheading:11709570-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:11709570-Carcinoma, Squamous Cell, pubmed-meshheading:11709570-Cell Count, pubmed-meshheading:11709570-Female, pubmed-meshheading:11709570-Humans, pubmed-meshheading:11709570-Immunoenzyme Techniques, pubmed-meshheading:11709570-Ki-67 Antigen, pubmed-meshheading:11709570-Lung Neoplasms, pubmed-meshheading:11709570-Male, pubmed-meshheading:11709570-Middle Aged, pubmed-meshheading:11709570-Neoplasm Staging, pubmed-meshheading:11709570-Nuclear Proteins, pubmed-meshheading:11709570-Prognosis, pubmed-meshheading:11709570-Survival Rate
pubmed:year
2001
pubmed:articleTitle
MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
pubmed:affiliation
Lung Cancer Program, Roswell Park Cancer Institute, Buffalo, NY, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't